Dermatology
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News
FDA approves second treatment for adults with hidradenitis suppurativa
Secukinumab was previously approved by the FDA for treatment of moderate to severe plaque psoriasis in adults, and several other indications.
Latest News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
Latest News
Phase 3 trial supports topical JAK inhibitor for AD in young children
Already approved in adolescents and adults, topical ruxolitinib was found safe and effective in children.
Latest News
Novel hydrogel holds promise for skin regeneration
The first clinical trials for treating complex diabetic wounds are planned for early 2024.
Latest News
Multicenter study aims to find new treatments for hidradenitis suppurativa
The effort includes collection of biospecimens for translational studies to drive drug development.
Latest News
Systematic review spotlights the use of nutraceuticals for acne
Zinc was the most studied nutraceutical, but there was substantial heterogeneity in the results.
From the Journals
Adolescents with atopic dermatitis more likely to have experienced bullying, study finds
“Clinicians, families, and schools should address and monitor bullying among adolescents.”
Latest News
FDA approves fixed dose combination topical treatment for acne
The new treatment combines three approved acne products for once-daily use.
Latest News
FDA proposes ban on hair straightener ingredients
The proposal specifies that formaldehyde would be banned, as well as other chemicals that release formaldehyde, such as methylene glycol.
Latest News
Once-weekly topical therapy shows promise for moderate to severe acne
In vitro studies have found that components of S. lacustris, a freshwater sponge, have effects that include antimicrobial activity...